BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 2009
View Archived Issues
Astellas Pharma discloses TrkA tyrosine kinase inhibitors for the treatment of urinary conditions
Read More
Janssen describes prokineticin-1 receptor antagonists for the treatment of gastrointestinal diseases
Read More
Hsp27 inhibitor OGX-427 well tolerated, affects tumor markers in phase I study
Read More
AVI BioPharma and CFI sign additional drug development contract for AVI-5038 in DMD
Read More
Boehringer Ingelheim discovers phosphodiesterase 4B inhibitors for the treatment of COPD
Read More
DSMB recommends continuation of phase III trial comparing Avexa's ATC to 3TC in HIV
Read More
Novel sphingosine-1-phosphate receptor agonists described by Pfizer
Read More
Novel calcium channel blockers emerge from Pfizer R&D
Read More
Belatacept shows immunosuppressant activity in phase II/III studies in kidney transplant recipients
Read More
NIAID initiates trial evaluating AEOL-10150 for treating radiation exposure
Read More
EyeGate Pharma reports that EGP-437 improves signs and symptoms of dry eye
Read More
Pharming receives EMEA agreement on pediatric investigation plan for Rhucin
Read More
CNTO-328 shows acceptable safety and promising activity in phase II trials in CRPC and MM patients
Read More
Ancora receives phase I SBIR grant from NIH to research SMA vaccine
Read More
ACT signs exclusive license for anticancer therapeutic from University of Louisville
Read More
Cytopia completes 3-year research term under 2006 collaboration with Novartis
Read More
Somaxon resubmits NDA for insomnia drug Silenor to FDA
Read More
CDA-1 and CDB-1 show efficacy in phase II study in C. difficile diarrhea
Read More
Phase II data on olaparib in breast, ovarian cancer reported at ASCO
Read More
Single i.v. dose of BG-9928 displays minimal effect on cardiac conduction in healthy volunteers
Read More
Nebivolol does not affect hemoglobin levels in chronic heart failure patients; SENIORS data suggest
Read More
Rolofylline fails to demonstrate efficacy for acute heart failure in phase III PROTECT study
Read More
PolyMedix initiates dosing in second phase I systemic antibiotic trial
Read More
Anadys initiates strategic restructuring to focus on development of ANA-598 in hepatitis C
Read More
FDA grants orphan drug designation to Delcath's melphalan for neuroendocrine tumors
Read More
Lpath receives grant from the NCI to use for lead candidate Asonep
Read More